Ticagrelor is Associated with Increased Rosuvastatin Blood Concentrations in Patients who have had a Myocardial Infarction. [PDF]
Dermota T +3 more
europepmc +1 more source
Pharmacodynamic effects of early aspirin withdrawal after percutaneous coronary intervention in patients with atrial fibrillation treated with ticagrelor or prasugrel. [PDF]
Sammut MA +12 more
europepmc +1 more source
Stent-assisted coiling and flow diversion with hpc-coated devices under prasugrel monotherapy in ruptured wide-neck aneurysms: a multicenter case series. [PDF]
Aburub A +12 more
europepmc +1 more source
Risk of major adverse cardiovascular events in CYP2C19 LoF genotype guided clopidogrel against alternative antiplatelets for CAD patients undergoing PCI: Meta-analysis. [PDF]
Biswas M +4 more
europepmc +1 more source
Cost-effectiveness of implementing a genotype-guided de-escalation strategy in patients with acute coronary syndrome. [PDF]
van den Broek WWA +17 more
europepmc +1 more source
Thromboelastography with Platelet Mapping to Optimize Surgical Timing in Coronary Artery Bypass Grafting Patients on P2Y12 Receptor Blockers Therapy. [PDF]
Dambruoso P +4 more
europepmc +1 more source
Drug-induced upper gastrointestinal bleeding: A real-world pharmacovigilance study. [PDF]
Wang B +10 more
europepmc +1 more source
Bleeding in Antiplatelet Therapy: A Narrative Review of Clinical Evidence and the Roles of Pharmacists and Nurses. [PDF]
Xu F, Zhang ZH, Li LC, Mao KL, Huang ZY.
europepmc +1 more source
<i>CYP2C19</i> Phenotype, P2Y<sub>12</sub> Inhibitor Selection, and Clinical Outcomes in Patients on Maintenance Clopidogrel Therapy. [PDF]
Patel RC +16 more
europepmc +1 more source
Association of Clopidogrel with Interstitial Lung Disease: Gaining Insight Through the Japanese Pharmacovigilance Database. [PDF]
Kozaru M +4 more
europepmc +1 more source

